Gan & Lee Pharmaceuticals. (603087.SS)
CNY 45.54
(0.35%)
CNY 45.54
(0.35%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.60 CNY | 176.92% |
| 2022 | -0.78 CNY | -130.12% |
| 2021 | 2.59 CNY | 18.26% |
| 2020 | 2.19 CNY | 5.29% |
| 2019 | 2.08 CNY | 12.43% |
| 2018 | 1.85 CNY | -13.55% |
| 2017 | 2.14 CNY | 40.79% |
| 2016 | 1.52 CNY | 70.79% |
| 2015 | 0.89 CNY | 45.9% |
| 2014 | 0.61 CNY | 38.64% |
| 2013 | 0.44 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.34 CNY | 112.5% |
| 2024 Q1 | 0.16 CNY | 23.08% |
| 2024 Q3 | 0.35 CNY | 2.94% |
| 2023 Q3 | 0.24 CNY | 60.0% |
| 2023 Q1 | 0.09 CNY | 291.48% |
| 2023 Q2 | 0.15 CNY | 71.04% |
| 2023 Q4 | 0.13 CNY | -45.83% |
| 2023 FY | - CNY | 176.92% |
| 2022 Q1 | 0.20 CNY | -80.77% |
| 2022 FY | - CNY | -130.12% |
| 2022 Q2 | -0.56 CNY | -380.0% |
| 2022 Q4 | -0.05 CNY | 88.26% |
| 2022 Q3 | -0.39 CNY | 30.36% |
| 2021 FY | - CNY | 18.26% |
| 2021 Q4 | 1.04 CNY | 16.85% |
| 2021 Q3 | 0.89 CNY | 169.7% |
| 2021 Q2 | 0.33 CNY | -2.94% |
| 2021 Q1 | 0.34 CNY | -66.34% |
| 2020 Q1 | 0.34 CNY | -64.21% |
| 2020 FY | - CNY | 5.29% |
| 2020 Q4 | 1.01 CNY | 44.29% |
| 2020 Q3 | 0.70 CNY | 94.44% |
| 2020 Q2 | 0.36 CNY | 5.88% |
| 2019 Q1 | 0.19 CNY | 0.0% |
| 2019 FY | - CNY | 12.43% |
| 2019 Q4 | 0.95 CNY | 28.38% |
| 2019 Q3 | 0.74 CNY | 117.65% |
| 2019 Q2 | 0.34 CNY | 78.95% |
| 2018 FY | - CNY | -13.55% |
| 2017 Q2 | 0.37 CNY | 0.0% |
| 2017 FY | - CNY | 40.79% |
| 2017 Q1 | 0.37 CNY | 0.0% |
| 2016 FY | - CNY | 70.79% |
| 2015 FY | - CNY | 45.9% |
| 2014 FY | - CNY | 38.64% |
| 2013 FY | - CNY | 0.0% |